• In Vitro Drug Response: Viability, Growth, and Death

  2026-08-20

  Hannah R. Schwartz’s dissertation examines why relative viability and fractional viability should not be treated as interchangeable measures of anticancer drug response. Its central contribution is a framework for separating proliferative arrest from cell killing, improving interpretation of drug potency, response timing, and experimental design.

• Remdesivir (GS-5734): Polymerase-Aware Assay Design

  2026-08-19

  Remdesivir and GS-5734 are examined through a polymerase-aware framework that connects coronavirus antiviral research and Ebola virus treatment research with emerging Nipah virus structural biology. The article emphasizes assay portability, orthogonal readouts, and the limits of inferring activity across distinct RNA virus polymerases.

• SAG Workflow for Hedgehog Pathway Research

  2026-08-19

  SAG is a versatile Smoothened receptor agonist for controlled Hedgehog pathway activation, from reporter assays and mitochondrial studies to myelin-regeneration models. Its strongest use-case advantage is experimental flexibility, but sex-dependent immune effects and developmental toxicity make dose, timing, and model selection essential.

• Sulforaphane: Redox Biology to Translational Strategy

  2026-08-18

  A mechanism-led perspective on Sulforaphane, connecting Keap1-Nrf2 signaling, cancer chemoprevention, G2/M arrest, apoptosis, and NLRP3-linked inflammation to rigorous translational workflows.

• RSL3: GPX4 Inhibitor for Ferroptosis Research

  2026-08-18

  RSL3 provides a direct pharmacological route to GPX4 inhibition, enabling controlled studies of ferroptosis, lipid peroxidation, and redox vulnerability. This guide translates the compound’s use into reproducible cell-based workflows and connects it with IGF2BP3–GPX4 regulation in glioma research.

• Dual-Action p38α Inhibitors and Dephosphorylation

  2026-08-17

  The reference preprint shows that selected p38α kinase inhibitors can do more than block catalysis: they also expose the activation-loop phosphothreonine to the phosphatase WIP1, accelerating p38α dephosphorylation. Structural and biochemical findings establish a design concept in which kinase conformation is used to improve the potency and specificity of inhibition of p38 MAPK signaling pathway.

• HyperScribe Co-transcription mRNA Synthesis Kit Plus

  2026-08-17

  Build translation-ready, ARCA-capped and polyadenylated transcripts for in vitro translation, RNA vaccine development, and functional RNA studies. This guide connects the HyperScribe workflow with a preclinical GPC3-HSP70 nanovaccine design and provides practical optimization and troubleshooting strategies.

• Ionophore Toxicity: Molecular Lessons for Salinomycin Resear

  2026-08-16

  Ekinci, Chłodowska, and Olejnik review how polyether ionophores produce species-, age-, and dose-dependent toxicity, with particular effects on myocardial and skeletal muscle cells. Their synthesis connects ion transport, disrupted oxidative phosphorylation, and drug interactions to practical considerations for evaluating Salinomycin and related compounds in translational research.

• Albiflorin Inhibits Renal Cell Carcinoma: Study Insights

  2026-08-15

  This study combines cell-based assays, network pharmacology, molecular docking, RT-qPCR, and pathway rescue experiments to investigate albiflorin in renal cell carcinoma (RCC). Its findings support inhibition of EGFR/MAPK signaling as a partial explanation for reduced RCC cell viability, proliferation, and migration, while also highlighting the need for in vivo and clinical validation.

• ML216 BLM Helicase Inhibitor Workflow

  2026-08-15

  ML216 enables controlled interrogation of BLM-dependent DNA repair, cell proliferation, sister chromatid exchange, and chemotherapy-sensitization phenotypes. This workflow also explains how to use ML216 alongside genetic controls when studying RecQ-helicase vulnerabilities in mismatch repair-deficient cancer models.

• N-octanoyl-L-Homoserine lactone in Cell Assays

  2026-08-14

  Use N-octanoyl-L-Homoserine lactone, also called C8-HSL, to model quorum-sensing-driven bacterial phenotypes and host-cell responses with defined exposure conditions. This practical guide connects biofilm and virulence assays with lung cancer cell workflows while emphasizing solvent control, fresh preparation, and pathway-level validation.

• Biotin-HPDP: Reversible Thiol Protein Labeling

  2026-08-14

  Biotin-HPDP is a sulfhydryl-reactive reagent for reversible, thiol-specific protein biotinylation. Its pyridyl disulfide chemistry supports streptavidin capture, DTT-mediated release, and controlled workflows for redox studies and detection of S-nitrosylated proteins.

• Hexa-Acylated LPS and Cancer Immunotherapy

  2026-08-13

  This study identifies the acylation state of gut microbiota-derived lipopolysaccharide, rather than bacterial taxonomy alone, as a functional determinant of anti-PD-1 response. Human metagenomic analysis and mouse intervention experiments show that hexa-acylated LPS can support TLR4-dependent antitumor immunity, while hypo-acylated LPS may oppose it.

• Angiotensin I/II (1-5): RAS Workflow Guide

  2026-08-13

  Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide fragment for controlled renin-angiotensin system research involving blood pressure regulation, renal physiology, and aldosterone release stimulation. It should not be treated as a general-purpose signaling reagent or used in aqueous workflows without addressing its documented water insolubility and solvent compatibility.

• Erastin: Practical Guide to Ferroptosis Research

  2026-08-12

  Use Erastin as a mechanistically informed ferroptosis inducer for testing redox vulnerabilities in RAS- or BRAF-altered tumor models. This guide connects routine cell-death assays with mitochondrial, lipid-peroxidation, and targeted nanotherapy workflows inspired by recent pancreatic cancer research.

460 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page